Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Karayama

Showing results (61-70 of 194) with videos related to

Pageof 20
Sort By:
Respiratory Medicine Case Reports|July 21, 2025
Severe drug-induced interstitial lung disease after photoimmunotherapy with cetuximab-sarotalocan sodium in a patient with oropharyngeal cancer: A case reportSho Takuma, Masato Karayama, Risa Suzuki, et al.
BMC Pulmonary Medicine|February 23, 2021
Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survivalYoichiro Aoshima, Masato Karayama, Yasuoki Horiike, et al.
The Clinical Respiratory Journal|June 7, 2018
Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosisNoriyuki Enomoto, Yoshiyuki Oyama, Yasunori Enomoto, et al.
Scientific Reports|February 21, 2020
Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired PneumoniaKazuo Tsuchiya, Yuzo Suzuki, Katsuhiro Yoshimura, et al.
The Journal of Rheumatology|January 17, 2019
Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched AnalysisHironao Hozumi, Tomoyuki Fujisawa, Ran Nakashima, et al.
Journal of Pain and Symptom Management|June 23, 2020
Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' ViewNorimichi Akiyama, Tomoyuki Fujisawa, Tatsuya Morita, et al.
Scientific Reports|May 26, 2019
Physiological and morphological differences of airways between COPD and asthma-COPD overlapMasato Karayama, Naoki Inui, Hideki Yasui, et al.
Therapeutic Advances in Respiratory Disease|February 13, 2020
Pulse oximetric saturation to fraction of inspired oxygen (SpO<sub>2</sub>/FIO<sub>2</sub>) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung diseaseTakafumi Koyauchi, Hideki Yasui, Noriyuki Enomoto, et al.
Respiratory Investigation|January 9, 2026
Epidemiology of interstitial lung diseases in Japan: A nationwide database analysisKoichi Miyashita, Yusuke Inoue, Hideki Yasui, et al.
Internal Medicine (Tokyo, Japan)|August 11, 2017
Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral FluoropyrimidineNorimichi Akiyama, Masato Karayama, Moriya Iwaizumi, et al.
Pageof 20

Showing results (61-70 of 194) with videos related to

Sort By:
Pageof 20
Respiratory Medicine Case Reports|July 21, 2025
Severe drug-induced interstitial lung disease after photoimmunotherapy with cetuximab-sarotalocan sodium in a patient with oropharyngeal cancer: A case reportSho Takuma, Masato Karayama, Risa Suzuki, et al.
BMC Pulmonary Medicine|February 23, 2021
Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survivalYoichiro Aoshima, Masato Karayama, Yasuoki Horiike, et al.
The Clinical Respiratory Journal|June 7, 2018
Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosisNoriyuki Enomoto, Yoshiyuki Oyama, Yasunori Enomoto, et al.
Scientific Reports|February 21, 2020
Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired PneumoniaKazuo Tsuchiya, Yuzo Suzuki, Katsuhiro Yoshimura, et al.
The Journal of Rheumatology|January 17, 2019
Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched AnalysisHironao Hozumi, Tomoyuki Fujisawa, Ran Nakashima, et al.
Journal of Pain and Symptom Management|June 23, 2020
Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' ViewNorimichi Akiyama, Tomoyuki Fujisawa, Tatsuya Morita, et al.
Scientific Reports|May 26, 2019
Physiological and morphological differences of airways between COPD and asthma-COPD overlapMasato Karayama, Naoki Inui, Hideki Yasui, et al.
Therapeutic Advances in Respiratory Disease|February 13, 2020
Pulse oximetric saturation to fraction of inspired oxygen (SpO<sub>2</sub>/FIO<sub>2</sub>) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung diseaseTakafumi Koyauchi, Hideki Yasui, Noriyuki Enomoto, et al.
Respiratory Investigation|January 9, 2026
Epidemiology of interstitial lung diseases in Japan: A nationwide database analysisKoichi Miyashita, Yusuke Inoue, Hideki Yasui, et al.
Internal Medicine (Tokyo, Japan)|August 11, 2017
Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral FluoropyrimidineNorimichi Akiyama, Masato Karayama, Moriya Iwaizumi, et al.
Pageof 20